Cargando…
Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriers
Non-manifesting carriers (NMCs) of Parkinson’s disease (PD)-related mutations such as LRRK2 and GBA are at an increased risk for developing PD. Dopamine transporter (DaT)-spectral positron emission computed tomography is widely used for capturing functional nigrostriatal dopaminergic activity. Howev...
Autores principales: | Droby, Amgad, Artzi, Moran, Lerman, Hedva, Hutchison, R. Matthew, Bashat, Dafna Ben, Omer, Nurit, Gurevich, Tanya, Orr-Urtreger, Avi, Cohen, Batsheva, Cedarbaum, Jesse M., Sapir, Einat Even, Giladi, Nir, Mirelman, Anat, Thaler, Avner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894349/ https://www.ncbi.nlm.nih.gov/pubmed/35241697 http://dx.doi.org/10.1038/s41531-022-00285-z |
Ejemplares similares
-
Neuromelanin and T(2)*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease
por: Ben Bashat, Dafna, et al.
Publicado: (2022) -
Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers
por: Thaler, Avner, et al.
Publicado: (2021) -
Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson’s disease
por: Thaler, Avner, et al.
Publicado: (2020) -
Whole brain and deep gray matter structure segmentation: Quantitative comparison between MPRAGE and MP2RAGE sequences
por: Droby, Amgad, et al.
Publicado: (2021) -
The Effect of GBA Mutations and APOE Polymorphisms on Dementia with Lewy Bodies in Ashkenazi Jews
por: Shiner, Tamara, et al.
Publicado: (2021)